全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1597440-03-3 | (Rac)-BRD0705;4-ethyl-7,7-dimethyl-4-phenyl-1,6,8,9-tetrahydropyrazolo[3,4-b]quinolin-5-one | C20H23N3O |
| 1598383-40-4 | EPZ 011989;N-[(1,2-Dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-3-[ethyl[trans-4-[(2-methoxyethyl)methylamino]cyclohexyl]amino]-2-methyl-5-[3-(4-morpholinyl)-1-propyn-1-yl]benzamide | C35H51N5O4 |
| 1599432-08-2 | (2E)-3-(4-Bromophenyl)-1-[4-(4-methoxybenzoyl)-1-piperazinyl]-2-propen-1-one;(2E)-3-(4-Bromophenyl)-1-[4-[(4-methoxyphenyl)carbonyl]piperazinyl]prop-2-en-1-one | C21H21BrN2O3 |
| 1599440-06-8 | [2-(Fmoc-amino)acetamido]methyl Acetate;[[2-(9H-fluoren-9-ylmethoxycarbonylamino)acetyl]amino]methyl acetate | C20H20N2O5 |
| 1599440-13-7 | Deruxtecan;6-(2,5-dioxopyrrol-1-yl)-N-[2-[[2-[[(2S)-1-[[2-[[2-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-2-oxoethoxy]methylamino]-2-oxoethyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-2-oxoethyl]hexanamide | C52H56FN9O13 |
| 1599466-81-5 | (SP-4-3)-[Dicyclohexyl[2',4',6'-tris(1-methylethyl)[1,1'-biphenyl]-2-yl]phosphine](methanesulfonato)[2'-(methylamino)[1,1'-biphenyl]-2-yl]palladium;XPhos Pd G4 | C47H64NO3PPdS |
| 1599466-83-7 | (SP-4-3)-[dicyclohexyl[3,6-dimethoxy-2',4',6'-tris(1-methylethyl)[1,1'-biphenyl]-2-yl]phosphine-κP](methanesulfonato-κO)[2'-(methylamino-κN)[1,1'-biphenyl]-2-yl-κC]-Palladium;BrettPhos Pd G4 | C49H68NO5PPdS |
| 1599466-85-9 | (SP-4-3)-[[2',6'-bis(1-methylethoxy)[1,1'-biphenyl]-2-yl]dicyclohexylphosphine-κP](methanesulfonato-κO)[2'-(methylamino-κN)[1,1'-biphenyl]-2-yl-κC]-Palladium | C44H58NO5PPdS |
| 1599466-87-1 | (SP-4-3)-[dicyclohexyl(2',6'-dimethoxy[1,1'-biphenyl]-2-yl)phosphine-κP](methanesulfonato-κO)[2'-(methylamino-κN)[1,1'-biphenyl]-2-yl-κC]-Palladium;SPhos Pd G4 | C40H50NO5PPdS |
| 1599466-89-3 | (SP-4-3)-[bis(1,1-dimethylethyl)[2',4',6'-tris(1-methylethyl)[1,1'-biphenyl]-2-yl]phosphine](methanesulfonato-κO)[2'-(methylamino-κN)[1,1'-biphenyl]-2-yl-κC]-Palladium;(Methanesulfonato-?O)[2'-(methylamino)-2-biphenylyl]palladium - bis(2-methyl-2-propanyl)(2',4',6'-triisopropyl-2-biphenylyl)phosphine (1:1) | C43H60NO3PPdS |
| 1599466-90-6 | rac-BINAP Pd G4;(SP-4-3)-[[2'-(Diphenylphosphino)[1,1'-binaphthalen]-2-yl]diphenylphosphine-?P](methanesulfonato-?O)[2'-(methylamino-?N)[1,1'-biphenyl]-2-yl-?C]palladium | C58H47NO3P2PdS |
| 1601460-92-7 | Carbocisteine Impurity 9;(3R)-3-Carboxy-5-oxo-4-thiomorpholineacetic acid | C7H9NO5S |
| 1602151-62-1 | 2-Amino-6-bromo-3,5-difluorobenzoic acid | C7H4BrF2NO2 |
| 1602859-53-9 | 4-Chloro-7-fluoro-3-iodo-6-methoxyquinoline | C10H6ClFINO |
| 1602922-03-1 | N-XantPhos Pd G3;Methanesulfonato[4,6-bis(diphenylphosphino)phenoxazine](2'-amino-1,1'-biphenyl-2-yl)palladium(II) | C49H40N2O4P2PdS |
| 1603814-04-5 | N-(4-Chloro-3-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine | C22H24ClFN4O3 |
| 1604810-83-4 | N-[3-[[5-Chloro-4-(1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-4-[[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]amino]benzamide | C31H28ClN7O2 |
| 1604812-35-2 | Azilsartan Impurity R;(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-3-[[4-[2-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-5-oxo-1,2,4-oxadiazol-3-yl]phenyl]phenyl]methyl]benzimidazole-4-carboxylate | C35H28N4O11 |
| 1604818-09-8 | 6-Chloro-3,3-dimethyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridine | C9H11ClN2 |
| 1604818-10-1 | tert-Butyl 6-chloro-3,3-dimethyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridine-1-carboxylate | C14H19ClN2O2 |
| 1605314-84-8 | Cefprozil Monohydrate EP Impurity M;(6R,7R)-7-[[(2R)-2-Amino-2-[4-[(ethoxycarbonyl)oxy]phenyl]acetyl]amino]-8-oxo-3-[(1Z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | C21H23N3O7S |
| 1605314-85-9 | Cefprozil Monohydrate EP Impurity N;(6R,7R)-7-[[(2R)-2-Amino-2-[4-(ethoxycarbonyl)oxy]phenyl]acetyl]amino]-8-oxo-3-[(1E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | C21H23N3O7S |
| 1607837-31-9 | 8-[2-Amino-3-chloro-5-(1-methyl-1H-indazol-5-yl)-4-pyridinyl]-2,8-diazaspiro[4.5]decan-1-one | C21H23ClN6O |
| 1608125-21-8 | (alphaS)-7-Fluoro-alpha-methyl-N-9H-purin-6-yl-2-(2-pyridinyl)-3-quinolinemethanamine;AMG 319 | C21H16FN7 |
| 1608459-56-8 | Prucalopride Impurity 20;4-amino-N-[1-(3-methoxypropyl)piperidin-4-yl]-2,3-dihydro-1-benzofuran-7-carboxamide | C18H27N3O3 |
| 1608495-96-0 | Folate-amido-C2-amine-endo-BCN;(2S)-2-[[4-[(2-amino-4-oxo-3H-pteridin-6-yl)methylamino]benzoyl]amino]-5-[2-[[(1R,8S)-9-bicyclo[6.1.0]non-4-ynyl]methoxycarbonylamino]ethylamino]-5-oxopentanoic acid | C32H37N9O7 |
| 1609073-29-1 | 2-Amino-4,5-bis[(4-methoxyphenyl)methoxy]benzoic acid | C23H23NO6 |
| 1609267-04-0 | 9-[1,1'-Biphenyl]-2-yl-3-bromo-9H-carbazole | C24H16BrN |
| 1609281-86-8 | 2-[(Aminocarbonyl)amino]-5-[4-(3,5-dimethyl-4-isoxazolyl)-2-[(3S)-3-pyrrolidinyloxy]phenyl]-3-thiophenecarboxamide | C21H23N5O4S |
| 1609373-91-2 | Benzofuro[2,3-b]pyridin-8-ol | C11H7NO2 |
| 1609373-98-9 | 1,1,1-Trifluoromethanesulfonic acid 2-methylbenzofuro[2,3-b]pyridin-8-yl ester;(2-methyl-[1]benzofuro[2,3-b]pyridin-8-yl) trifluoromethanesulfonate | C13H8F3NO4S |
| 1609392-27-9 | Deucravacitinib;6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide | C20D3H19N8O3 |
| 1609402-14-3 | N-[4-[3-[[[5-(Dimethylamino)-1-naphthalenyl]sulfonyl]amino]phenyl]-2-thiazolyl]acetamide | C23H22N4O3S2 |
| 1609402-46-1 | N-(5-Chloro-3-hydroxy-2-pyridinyl)carbamic acid 1,1-dimethylethyl ester | C10H13ClN2O3 |
| 1609484-28-7 | 3-Bromospiro[9H-fluorene-9,9'-[9H]xanthene] | C25H15BrO |
| 1609484-45-8 | 4-Bromospiro[9H-fluorene-9,9'-[9H]xanthene] | C25H15BrO |
| 1609484-77-6 | N-([1,1'-Biphenyl]-3-yl)-[1,1':3',1''-terphenyl]-4'-amine | C30H23N |
| 1609584-72-6 | 1-[3-Methoxy-4-[[6-[[2-[(1-methylethyl)sulfonyl]phenyl]amino]-9H-purin-2-yl]amino]phenyl]-4-piperidinol | C26H31N7O4S |
| 1609960-30-6 | 6-(2,3-Dichlorophenyl)-N4-methyl-2,4-pyrimidinediamine;TH 287 | C11H10Cl2N4 |
| 1609960-31-7 | N4-Cyclopropyl-6-(2,3-dichlorophenyl)-2,4-pyrimidinediamine;TH 588 | C13H12Cl2N4 |
| 1610413-97-2 | 12-(4-((9S,13S)-9,13-Bis(tert-butoxycarbonyl)-18,18-dimethyl-3,11,16-trioxo-17-oxa-2,4,10,12-tetraazanonadecyl)phenyl)acetic acid | C34H54N4O10 |
| 1610527-49-5 | 2,4-Dimethyl-1-[(2-nitrophenyl)thio]benzene | C14H13NO2S |
| 1610882-30-8 | (2S)-1-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)-3,3-dimethyl-2-[(4-pyridinylmethyl)amino]-1-butanone hydrochloride (1:1);TCS-OX 2-29 | C23H31N3O3.HCl |
| 1611469-80-7 | 1-(3-Bromopropyl)-4-octylbenzene | C17H27Br |
| 1611490-64-2 | UDP-GlcNAz.2Na;Uridine 5-disphopho-N-acetylazidoglucosamine disodium salt | C17H24N6O17P2Na2 |
| 1611493-60-7 | Bictegravir;(2R,5S,13aR)-2,3,4,5,7,9,13,13a-Octahydro-8-hydroxy-7,9-dioxo-N-[(2,4,6-trifluorophenyl)methyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide; GS 9883 | C21H18F3N3O5 |
| 1612153-32-8 | (4R)-3-[(5R)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-4-phenyl-2-oxazolidinone | C20H20FNO4 |
| 1612191-86-2 | (3alpha,5beta,6alpha,7alpha)-6-Ethyl-24-norcholane-3,7,23-triol | C25H44O3 |
| 1612888-66-0 | Alofanib;3-[[[4-Methyl-2-nitro-5-(3-pyridinyl)phenyl]amino]sulfonyl]benzoic acid | C19H15N3O6S |
| 1613028-81-1 | N-[2-(3-Bromophenyl)ethyl]-2,4,6-trimethyl-N-[[3'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]methyl]benzenesulfonamide | C31H32BrNO4S2 |